https://www.live-feeds.com/feed/experimental-weight-loss-drug-eases-painful-knee-osteoarthritis-in-two-clinical-trialsContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/experimental-weight-loss-drug-eases-painful-knee-osteoarthritis-in-two-clinical-trialshttps://www.live-feeds.com/feed/experimental-weight-loss-drug-eases-painful-knee-osteoarthritis-in-two-clinical-trials#u196892Thu, 12 Nov 2026 11:06:44 +0000New Phase III clinical trial research published in the New England Journal of Medicine demonstrates that the experimental weight-loss drug retatrutide provides significant pain relief and weight reduction for people with knee osteoarthritis and obesity. In trials involving more than 1,000 participants combined, individuals taking the highest dose of the injectable drug lost roughly one-quarter of their body weight on average. And about two-thirds of the participants experienced at least a 50 percent reduction in their knee pain, improving physical function for everyday activities.Why it matter